Search

everythinglearnresearchcommunity

for

Search:↓

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Finasteride treats hair loss but may affect prostate cancer detection.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

SCDSFs from zebrafish embryos are beneficial for treating cancer, regenerating tissues, and improving conditions like psoriasis and alopecia.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

CEC levels may be a useful marker for predicting prostate cancer progression.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Gene variation affects prostate issues and hair loss.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

Kolaviron and quercetin may help treat prostate issues.

More prostate biopsies increase the chance of finding cancers that may not need treatment.